trending Market Intelligence /marketintelligence/en/news-insights/trending/u1D3RngouAGuvV7Kuv4-eA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Ohr Pharmaceutical granted extension to meet Nasdaq compliance

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021

Six trends shaping the industries and sectors we cover in 2021


Ohr Pharmaceutical granted extension to meet Nasdaq compliance

Ohr Pharmaceutical Inc. was granted additional time to regain compliance with Nasdaq's minimum $1 bid price listing requirement.

The pharmaceutical company now has an additional 180 calendar days, or until April 2, 2018, to meet the listing standard.

It had received the noncompliance notice April 6 and had until Oct. 3 to regain compliance.